HAEMATOCOCCUS PLUVIALIS MODULATING EFFECT ON NEUROTRANSMITTERS, HORMONES AND OXIDATIVE DAMAGE-ASSOCIATED WITH ALZHEIMER´S DISEASE IN EXPERIMENTAL RAT´S MODEL

Abstract

Objective: This study was planned to assess the efficacy of Haematococcus pluvialis in the regression of Alzheimer’s disease (AD).Methods: Fifty rats were divided into five groups. Positive control group orally received aluminium chloride in a dose 100 mg/kg to induce AD: AD induced rats were orally treated with H. pluvialis extract (150 mg/kg) and rivastigmine standard drug (4.6 mg/kg/day) for 30 d. Brain acetylcholine esterase (AchE), acetylcholine (Ach), dopamine (DA), adrenaline (A), noradrenaline (NA), oxidative stress biomarkers and superoxide dismutase (SOD) were determined. Further, adrenocorticotropic hormone (ACTH) and cortisol (CORT) levels were evaluated. Also, brain histopathological investigation was examined.Results: AD induced rats recorded a significant increase in the brain AchE, concomitant with a significant decrease in Ach, DA, NA, A and SOD levels. While, a significant increase in NO and H2O2, CORT and ACTH was recorded. Moreover, brain histopathological investigation in AD rats showed the formation of amyloid plaques and necrosis of neurons. Treatment of AD induced rats with extract of H. pluvialis or standard drug resulted in an improvement in the most of the all studied biochemical parameters. Also, AD groups treated with extract or standard drug showed great improvement in the brain morphological structure with normalisation of cerebral cortex and hippocampus, though, necrosis of some cerebral neurones was detected.Conclusion: This current study indicated that H. pluvialis extract and drug significantly ameliorates the neurotransmitters level, oxidative damage as well as pituitary function due to their anticholinesterase activity, antioxidant efficacy, beside the anti-inflammatory effect.

Authors and Affiliations

Farouk K. El-baz, Hanan F. Aly, Gamila H. Ali

Keywords

Related Articles

DEVELOPMENT AND VALIDATION OF HPLC/UV METHOD FOR DETERMINATION OF MELOXICAM IN HUMAN PLASMA AND APPLICATION IN PHARMACOKINETIC STUDIES

Objective: To develop and validate a modified isocratic reversed-phase high performance liquid chromatographic/ultraviolet (RP-HPLC/UV) method for determination of Meloxicam in human plasma to be used for pharmacokinetic...

COMPARATIVE STUDY OF KANAMYCIN AND CAPREOMYCIN ON SERUM POTASSIUM LEVEL OF MULTIDRUG RESISTANCE TUBERCULOSIS PATIENTSAT A HOSPITAL IN BANDUNG, INDONESIA

Objective: Kanamycin and capreomycin are the second lines injectable ant tuberculosis used in therapy regimen of multidrug resistance tuberculosis (MDR TB) in Indonesia. Both have effects on serum potassium levels and ca...

CYTOTOXICITY STUDY OF ANTIDIABETIC PLANTS ON NEUROBLASTOMA CELLS CULTURED AT NORMAL AND HIGH GLUCOSE LEVEL

Objective: In diabetes, chronic hyperglycemia causes damage (glucose toxicity) on some cells leading to micro and macro vascular complications. The aim of this study was to investigate the effect of antidiabetic plants e...

A PROSPECTIVE COMPARATIVE OBSERVATIONAL STUDY ON SAFETY, EFFICACY AND COST EFFECTIVENESS OF INSULIN AND THEIR ANALOGUES

Objective: The objective of this study was to compare safety, efficacy and cost effectiveness of insulin and their analogues when compared with human insulin in patients with type-2 diabetes mellitus.Methods: A prospec...

CURRY LEAVES AS ALTERNATIVE MEDICINE IN HEAVY METAL INDUCED OCCUPATIONAL HEALTH HAZARDS

Workers in different industries are regularly exposed to heavy metals. Those metals enter their body through several routes (inhalation, food contamination etc.,) and accumulate in the tissues and induce generation of re...

Download PDF file
  • EP ID EP575841
  • DOI 10.22159/ijpps.2017v9i2.15797
  • Views 79
  • Downloads 0

How To Cite

Farouk K. El-baz, Hanan F. Aly, Gamila H. Ali (2017). HAEMATOCOCCUS PLUVIALIS MODULATING EFFECT ON NEUROTRANSMITTERS, HORMONES AND OXIDATIVE DAMAGE-ASSOCIATED WITH ALZHEIMER´S DISEASE IN EXPERIMENTAL RAT´S MODEL. International Journal of Pharmacy and Pharmaceutical Sciences, 9(2), 198-206. https://europub.co.uk/articles/-A-575841